AzTrials
AzTrials

AnxietyRELACSNCT04796389

Music for Anxiety in Critically Ill Patients

A study testing Music in people with Anxiety, run by Erasmus Medical Center at 3 sites in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Rationale: Anxiety is common in critically ill patients, and has likely become more prevalent in the recent decade due to the imperative of the recent PADIS guidelines to use low levels of sedation and strive for wakefulness. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anxiety
What is being tested?
Music
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
3 sitesNetherlands
Study dates
24 Aug 2020to 1 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient is hemodynamically stable and communicable (RASS of -2 or higher in the 24h before intended inclusion: meaning patient is at least briefly awakened with eye contact to voice).
  • Expected ICU stay upon randomisation of at least another 48 hours.
  • Written informed consent acquired from the patient or legal representative.

Who cannot join

  • Patients with severe hearing impairment, defined as no verbal communication possible.
  • Neurological condition (e.g. severe stroke), when deemed to interfere with processing of music (e.g. not applicable to patients with minor stroke in past medical history without significant residual neurological deficits; those patients could be included).
  • Insufficient knowledge of the Dutch or English language for informed consent.
  • Participation in another study that may possibly intervene with the primary outcome measure

Trial locations and contacts

3 sites in 1 country.

Netherlands3 sites
  • Erasmus MC

    Rotterdam, South Holland, 3015 GD

  • Ikazia

    Rotterdam, South Holland, 3083 AN

  • HagaZiekenhuis

    The Hague, South Holland, 2545 AA

Other trials in Netherlands

About this study

Official title: Result of a Music Intervention on Anxiety in Critically Ill Patients

Rationale: Anxiety is common in critically ill patients, and has likely become more prevalent in the recent decade due to the imperative of the recent PADIS guidelines to use low levels of sedation and strive for wakefulness. Administration of sedative and analgesic medication is often chosen to reduce anxiety, especially when associated with agitation, but especially sedatives are associated with prolonged mechanical ventilation, delirium and muscle wasting and are therefore preferably minimized. Previous studies have suggested positive effects of music interventions on anxiety in the critically ill, next to other physiological signs such as pain. However, management of anxiety has not been included in the PADIS guidelines, and there is lack of evidence to treat it in spite of its growing importance. Therefore, we aim to study the effect of music intervention on anxiety in adult critically ill patients.

Objective: The primary objective is to assess the effect of music intervention on the level of anxiety.

Read more

Study design: A randomized controlled trial. Study population: Adult patients admitted to the intensive care unit, with whom communication is possible (Richmond Agitation Sedation Scale of -2 or higher).

Intervention (if applicable): The music group will be offered to listen to music two times per day for three days after inclusion, during 30-60 minutes per session. Chosen music will be based on the preference of the patient. The control group will receive standard of care during the entire study.

Main study parameters/endpoints: The primary outcome is the effect of music on the Visual Analogue Scale for anxiety (VAS-A). Secondary outcomes include effect of music on sedation and agitation level, medication requirement, pain, sleep, delirium, heart rate, mean arterial pressure, and ICU memory and experience.

Conditions
Anxiety
Being tested
Music
Keywords
music, anxiety, intensive care unit, critically ill
Medical subject headings
Anxiety Disorders, Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MusicOther

    Preferred music of the participant administered using headphones.

Study groups in NCT04796389
Study groupRoleWhat they receive
Recorded musicExperimentalRecorded music intervention
Receives: Other: Music
ControlNo interventionStandard of care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anxiety (VAS-A)

    Measured using the Visual Analogue Scale for Anxiety (VAS-A), on a scale of 0 to 10, in which a higher score means a worse outcome.

    Measured: 1.5 year

Secondary outcomes (10)
  1. Anxiety (STAI-6)

    Measured using the 6-item State- Trait Anxiety Inventory (STAI-6), on a scale of 20 to 80, in which a higher score means a worse outcome.

    Measured: 1.5 year

  2. Sleep quality

    Measured using a 7-item questionnaire, on a scale of 1 to 7, in which a lower score means a worse outcome.

    Measured: 1.5 year

  3. Delirium

    Measured with the Intensive Care Delirium Screening Checklist (ICDSC), on a scale of 0 to 8, in which a score of 4 or higher indicates delirium.

    Measured: 1 year

  4. Sedative and opioid medication requirement

    Including remifentanyl, propofol, benzodiazepines, dexmedetomidine, clonidine, paracetamol, sufentanyl, fentanyl, morphine, ketamine, epidural analgesia, haloperidol, and other benzodiazepines, atypical anxiolytics and antipsychotics.

    Measured: 1.5 year

  5. ICU memory and experience

    Assessed by the ICU memory tool (ICU-MT), difference is assessed per item.

    Measured: 1.5 year

  6. Agitation and sedation level

    Assessed using the Richmond- Agitation- Sedation Scale (RASS), on a scale of -5 to +4, negative scores indicate level of sedation (a more negative score indicates deeper sedation) and positive scores indicate levels of agitation (the higher the score the more agitated the patient).

    Measured: 1.5 year

  7. Complications

    Complications related to agitation, defined as removal of lines and tube by the patient.

    Measured: 1.5 year

  8. Level of Pain

    Measured using the Critical-Care Pain Observation (CPOT), on a scale of 0 to 8, in mechanically ventilated patients, or the NRS/VAS, on a scale of 0 to 10, for pain in non-ventilated and alert/oriented.

    Measured: 1.5 year

  9. Heart Rate (HR)

    Heart Rate at the time of anxiety assessment in beats per minute.

    Measured: 1.5 year

  10. Mean Arterial Pressure (MAP)

    Mean Arterial Pressure at the time of anxiety assessment in mmHg.

    Measured: 1.5 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2021
  2. Study start24 Aug 2020
  3. Primary completion1 Dec 2021
  4. Study completion1 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Randomized controlled trial
Masking
None (open label)
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04796389
Sponsor's protocol ID
MEC-2020-0212
Acronym
RELACS
Status last verified
Apr 2022
First submitted
4 Mar 2021
Last updated
13 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Kakar E, Ottens T, Stads S, Wesselius S, Gommers DAMPJ, Jeekel J, van der Jagt M. Effect of a music intervention on anxiety in adult critically ill patients: a multicenter randomized clinical trial. J Intensive Care. 2023 Aug 17;11(1):36. doi: 10.1186/s40560-023-00684-1.

    PubMed 37592358
  • Kakar E, Van Mol M, Jeekel J, Gommers D, van der Jagt M. Study protocol for a multicentre randomised controlled trial studying the effect of a music intervention on anxiety in adult critically ill patients (The RELACS trial). BMJ Open. 2021 Oct 12;11(10):e051473. doi: 10.1136/bmjopen-2021-051473.

    PubMed 34642197

Questions about this trial

What is this clinical trial studying?

A study testing Music in people with Anxiety, run by Erasmus Medical Center at 3 sites in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anxiety (VAS-A) (time frame: 1.5 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04796389, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in